Methyl-Me
NGS based Methylation toolkit for the detection, classification and monitoring of cancers
![](https://www.methylomics.nl/wp-content/uploads/2024/04/Methyl-me-sample-148x123xc.png)
Sample
- Biopsies
- Blood (cfDNA)
![](https://www.methylomics.nl/wp-content/uploads/2024/04/pijl-76x108xc.png)
![](https://www.methylomics.nl/wp-content/uploads/2024/04/Methyl-me-AI-170x159xc.png)
Classification algorithm
Differentiating samples based on patterns for
- General cancer methylation
- Tissue specific methylation
- Cancer subtype methylation
![](https://www.methylomics.nl/wp-content/uploads/2024/04/pijl-76x108xc.png)
![](https://www.methylomics.nl/wp-content/uploads/2024/04/Methyl-me-Diagnosis-163x221xc.png)
Diagnosis
Output
- Cancer (Yes/No)
- Cancer tissue type
- Cancer subtype
- Tumor Tissue of Origin
- Disease status
![](https://www.methylomics.nl/wp-content/uploads/2024/04/pijl-76x108xc.png)
![](https://www.methylomics.nl/wp-content/uploads/2024/04/Methyl-me-Personalized-medicine-171x162xc.png)
Personalized medicine
Risk assesment > Prognosis > Personalized treatment plan > Treatment monitoring > Treatment succes determniation (MRD)